Lighthouse Clinic
Lilongwe, P/Bag A-104, Malawi
NCT Number: NCT02646605
Quantitative, validated tools of depression screening will be used to collect data to determine the prevalence of depression and its association with antiretroviral (ARV) adherence amongst HIV positive patients attending ART clinic at Lighthouse Lilongwe, Malawi.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lilongwe, P/Bag A-104, Malawi
Preliminary data on prevalence and associations will be collected from 200 HIV positive adult men and women attending ART clinic at the Lighthouse in Lilongwe, Malawi. Quantitative, validated tools of depression screening will be used. A short structured demographic questionnaire will be used to collect demographic data. For depression, a Patient Health Questionnaire (PHQ) will be used while alcohol use will be assessed by Alcohol Use Disorders Identification Test (AUDIT) screening tool. The data collected will provide baseline data planning, program development and evaluation, and to promote comprehensive care provision for the people living with AIDS attending ART clinics in Malawi.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient Health Questionnaire
Time frame: enrollment
the survey will be administered one time
University of North Carolina, Chapel Hill
Other
Prevalence of Depression Amongst HIV Positive Patients Attending ART Clinic at Lighthouse Clinic, Lilongwe
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02620150
AIDS, Acquired Immunodeficiency Syndrome
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07032363
AIDS, Acquired Immunodeficiency Syndrome
Miami, Florida, United States
View Trial DetailsNCT03670316
AIDS, Acquired Immunodeficiency Syndrome
Birmingham, Alabama, United States
View Trial DetailsNCT06282328
AIDS, Acquired Immunodeficiency Syndrome
Milan, Italy
View Trial Details